Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids
- PMID: 27753007
- DOI: 10.1007/7854_2016_17
Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids
Abstract
Originally developed as research tools for use in structure-activity relationship studies, synthetic cannabinoids contributed to significant scientific advances in the cannabinoid field. Unfortunately, a subset of these compounds was diverted for recreational use beginning in the early 2000s. As these compounds were banned, they were replaced with additional synthetic cannabinoids with increasingly diverse chemical structures. This chapter focuses on integration of recent results with those covered in previous reviews. Whereas most of the early compounds were derived from the prototypic naphthoylindole JWH-018, currently popular synthetic cannabinoids include tetramethylcyclopropyl ketones and indazole-derived cannabinoids (e.g., AB-PINACA, AB-CHMINACA). Despite their structural differences, psychoactive synthetic cannabinoids bind with high affinity to CB1 receptors in the brain and, when tested, have been shown to activate these receptors and to produce a characteristic profile of effects, including suppression of locomotor activity, antinociception, hypothermia, and catalepsy, as well as Δ9-tetrahydrocannabinol (THC)-like discriminative stimulus effects in mice. When they have been tested, synthetic cannabinoids are often found to be more efficacious at activation of the CB1 receptor and more potent in vivo. Further, their chemical alteration by thermolysis during use and their uncertain stability and purity may result in exposure to degradants that differ from the parent compound contained in the original product. Consequently, while their intoxicant effects may be similar to those of THC, use of synthetic cannabinoids may be accompanied by unpredicted, and sometimes harmful, effects.
Keywords: Cannabinoids; Indoles; JWH-018; Receptor binding; Synthetic cannabinoids; THC.
Similar articles
-
AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.J Pharmacol Exp Ther. 2015 Sep;354(3):328-39. doi: 10.1124/jpet.115.225326. Epub 2015 Jun 23. J Pharmacol Exp Ther. 2015. PMID: 26105953 Free PMC article.
-
Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids.Life Sci. 2014 Feb 27;97(1):55-63. doi: 10.1016/j.lfs.2013.09.011. Epub 2013 Sep 23. Life Sci. 2014. PMID: 24071522 Free PMC article. Review.
-
Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.Neuropharmacology. 2013 Dec;75:145-54. doi: 10.1016/j.neuropharm.2013.07.022. Epub 2013 Aug 2. Neuropharmacology. 2013. PMID: 23916483 Free PMC article.
-
Analysis of the pharmacological properties of JWH-122 isomers and THJ-2201, RCS-4 and AB-CHMINACA in HEK293T cells and hippocampal neurons.Eur J Pharmacol. 2018 Mar 15;823:96-104. doi: 10.1016/j.ejphar.2018.01.043. Epub 2018 Feb 4. Eur J Pharmacol. 2018. PMID: 29408093
-
Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.Curr Top Behav Neurosci. 2017;32:249-262. doi: 10.1007/7854_2016_60. Curr Top Behav Neurosci. 2017. PMID: 28012093 Free PMC article. Review.
Cited by
-
Molecular Targets of Cannabinoids Associated with Depression.Curr Med Chem. 2022;29(11):1827-1850. doi: 10.2174/0929867328666210623144658. Curr Med Chem. 2022. PMID: 34165403 Free PMC article. Review.
-
In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists.Pharmacol Biochem Behav. 2022 Oct;220:173467. doi: 10.1016/j.pbb.2022.173467. Epub 2022 Sep 22. Pharmacol Biochem Behav. 2022. PMID: 36154844 Free PMC article.
-
The Spicy Story of Cannabimimetic Indoles.Molecules. 2021 Oct 14;26(20):6190. doi: 10.3390/molecules26206190. Molecules. 2021. PMID: 34684770 Free PMC article. Review.
-
Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18.Biomolecules. 2020 Apr 29;10(5):686. doi: 10.3390/biom10050686. Biomolecules. 2020. PMID: 32365486 Free PMC article.
-
Differential cannabinoid-like effects and pharmacokinetics of ADB-BICA, ADB-BINACA, ADB-4en-PINACA and MDMB-4en-PINACA in mice: A comparative study.Addict Biol. 2024 Feb;29(2):e13372. doi: 10.1111/adb.13372. Addict Biol. 2024. PMID: 38380735 Free PMC article.
References
-
- Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605–613 - PubMed
-
- Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561–564 - PubMed
-
- Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61–64 - PubMed
-
- Howlett AC, Bidaut-Russell M, Devane WA, Melvin LS, Johnson MR, Herkenham M (1990) The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci 13:420–423 - PubMed
-
- Pertwee RG (2008) Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol 13:147–159 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials